Switchable Enzyme‐Regulated ECM‐Integrin‐Cholesterol Signaling Orchestrate PD‐L1 Dual Destabilization for Boosting Photo‐Immunotherapy
Small · 2026
DOI: 10.1002/smll.202513901 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Wenbo Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Lab of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Cholesterol, B7-H1 Antigen, Signal Transduction, Extracellular Matrix. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China, Natural Science Foundation of Tianjin City.
Abstract (Originalsprache)
Although PD‐1/PD‐L1 blockade therapy has shown clinical success, its efficacy in solid tumors remains limited by the immunosuppressive tumor microenvironment. The tumor extracellular matrix (ECM), which forms a dense physical barrier and activates integrin‐mediated mechanotransduction to upregulate PD‐L1, while cholesterol‐enriched membrane domains stabilize integrin clustering and PD‐L1 localization, forming a self‐reinforcing ECM‐integrin‐cholesterol signaling network that drives immune evasion. Here, we designed a switchable natural enzyme nanoplatform with dual safety locks, co‐delivering papain and cholesterol synthesis inhibitor simvastatin to disrupt this network at multiple levels. Papain remains inactive during systemic circulation and intracellular trafficking, ensuring biosafety, but is selectively activated by tumor‐released glutathione and boosted by localized photothermal heating to precisely degrade ECM, suppressing integrin signaling and PD‐L1 transcription, while simvastatin‐driven cholesterol depletion amplifies this effect by destabilizing integrin clusters and promoting PD‐L1 degradation. Combined with phototherapy‐induced immunogenic cell death, this strategy remodels ECM, enhances T cell infiltration, overcomes checkpoint blockade resistance, and eradicates advanced tumors (∼500 mm 3 ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Lab of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, China.
- Tianjin Key Laboratory of Molecular Recognition and Biosensing, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin, China.
- School of Science and Engineering, Shenzhen Key Laboratory of Functional Aggregate Materials, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.
ORCID-Profile: Yue Wang, Xiue Jiang
Förderung
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin City
- Natural Science Foundation of Tianjin Municipality
Zitieren
APA
Yin, W., Wang, Y., Liu, Z., An, S., Song, T., & Jiang, X. (2026). Switchable Enzyme‐Regulated ECM‐Integrin‐Cholesterol Signaling Orchestrate PD‐L1 Dual Destabilization for Boosting Photo‐Immunotherapy. Small. https://doi.org/10.1002/smll.202513901
Vancouver
Yin W, Wang Y, Liu Z, An S, Song T, Jiang X. Switchable Enzyme‐Regulated ECM‐Integrin‐Cholesterol Signaling Orchestrate PD‐L1 Dual Destabilization for Boosting Photo‐Immunotherapy. Small. 2026. doi:10.1002/smll.202513901
BibTeX
@article{Yin2026,
author = {Yin, Wenbo and Wang, Yue and Liu, Zonghang and An, Shangjie and Song, Tao and Jiang, Xiue},
title = {Switchable Enzyme‐Regulated ECM‐Integrin‐Cholesterol Signaling Orchestrate PD‐L1 Dual Destabilization for Boosting Photo‐Immunotherapy},
journal = {Small},
year = {2026},
doi = {10.1002/smll.202513901}
}
EUVIMED